Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody ?-glucuronidase conjugate
- 28 December 2000
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 91 (4) , 550-554
- https://doi.org/10.1002/1097-0215(200002)9999:9999<::aid-ijc1075>3.0.co;2-l
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Novel anthracycline-spacer-β-glucuronide, -β-glucoside, and -β-galactoside prodrugs for application in selective chemotherapyBioorganic & Medicinal Chemistry, 1999
- Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapyBiochemical Pharmacology, 1996
- Prodrugs of anticancer agentsAdvanced Drug Delivery Reviews, 1996
- Improved Characteristics of a Human β-Glucuronidase−Antibody Conjugate after Deglycosylation for Use in Antibody-Directed Enzyme Prodrug TherapyBioconjugate Chemistry, 1996
- Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.The Journal of cell biology, 1994
- Antibodies as Carriers of CytotoxicityPublished by S. Karger AG ,1992
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.Proceedings of the National Academy of Sciences, 1988
- The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamineBiochemical Journal, 1980
- β-Glucuronidase and the Hydrolysis of GlucuronidesPublished by Elsevier ,1966